RESPONSE BIOMEDICAL CORP Deferred Tax Assets, in Process Research and Development

RESPONSE BIOMEDICAL CORP Deferred Tax Assets, in Process Research and Development

RESPONSE BIOMEDICAL CORP had Deferred Tax Assets, in Process Research and Development of CAD 5.68 million as of 2012-12-31, per its 10-K filed 2013-03-15.

Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2013-03-15

• 2012-12-31: Deferred Tax Assets, in Process Research and Development 5.68M CAD.
• 2011-12-31: Deferred Tax Assets, in Process Research and Development 5.81M CAD.